Tiotropium Inhaler
This inhaler is formulated to support respiratory function and indicated to alleviate airway narrowing in chronic obstructive pulmonary disease.
Strengths: 9mcg
Where to Check Availability
Medicine details
- Alternative names
Spiriva
- Therapeutic class
Antimuscarinic
- Pharmacological class
Long-acting muscarinic antagonist (LAMA)
- Contraindications
hypersensitivity to tiotropium; hypersensitivity to atropine or derivatives
- Minor side effects
dry mouth; cough; pharyngitis
- Moderate side effects
constipation; gastro-oesophageal reflux; tachycardia; blurred vision
- Dosage forms
Inhalation powder; Inhalation solution
- Administration route
Inhalation use
- Prescription status
POM
- Manufacturer
Boehringer Ingelheim
- Onset Time
30 mins
- Duration
24 hours
- Storage instructions
Store in original device at room temperature.
- Drug interactions
other anticholinergics
- Age restrictions
Consult specialist for paediatric use.
- Pregnancy and breastfeeding
Pregnancy: Use with caution. Breastfeeding: Use with caution.
Precautions and warnings
avoid getting powder in eyes; not for use in acute bronchospasm; use caution in prostatic hyperplasia
Serious side effects
paradoxical bronchospasm — requires immediate medical attention; glaucoma — requires immediate medical attention
Patient summary
This inhaler is formulated to support respiratory function and indicated to alleviate airway narrowing in chronic obstructive pulmonary disease.
Mechanism of action
Tiotropium binds to muscarinic receptors on airway smooth muscle, inhibiting bronchoconstriction and maintaining bronchodilation over an extended period.
Tiotropium Inhaler
This inhaler is formulated to support respiratory function and indicated to alleviate airway narrowing in chronic obstructive pulmonary disease.
Editorial Notes
- Active ingredient(s): Tiotropium
- Listed indication(s): Chronic Obstructive Pulmonary Disease, Asthma
Available option
- 3 inhalers - 9 mcg1331-9-mcg-15955